At-Home Drug of Abuse (DOA) Testing Market - Growth, Trends, and Forecasts (2020 – 2025)

The At-Home Drug of Abuse (DOA) Testing Market is segmented by Type(Test Cups, Test Strips, Others), Sample Type and by Geography.

Market Snapshot

CAGR
Study Period: 2017-2025
Base Year: 2019
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The surge in the number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others, is one of the major drivers for market growth. Developed countries such as the United States have stringent laws for drug abuse and have mandated alcohol and drug testing to take legal action against addicts and abusers for the sake of limiting violence or accidents. Furthermore, the increasing overdose of prescription drugs and the diagnosis of these drugs and their metabolites is boosting the at-home drug of abuse testing market. According to the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults engaged in a substance use disorder in 2017. However, lack of awareness of these testing devices is a constraint to the market growth.

Scope of the Report

As per the scope of the report, At-Home Drug of Abuse (DOA) Testing is rapid test kits that can be used at home and present their results swiftly, in an easy method that anybody can understand them. This report is segmented by Type, Sample Type, and Geography.

By Type
Test Cups
Test Strips
Others
By Sample Type
Saliva
Urine
Blood
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Analysis of Urine is Expected to be the Dominant Segment by Sample Type Over the Forecast Period.

The dominant share of the segment is attributed to the advantages of drug of abuse testing using a urine sample. Detection through urine sample is the easiest and most affordable way, both illegal and prescription drugs can be checked for. The major advantage of the test is that the analysis can determine if specific drugs are used in the past few days or weeks, even after the effects of the drugs have worn off. Apart from the advantages the increasing drug consumption and increasing need to check the drug levels at home is boosting the segment growth. In 2018, there were an estimated 34.1 million young adults who suffered from both a mental health disorder and a substance use disorder or co-occurring disorders as per American Addiction Center. With this huge number of people suffering the segment and the market is tend to grow at a higher rate in the forecast period.

drug use

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The dominant position of the market in this region is mainly due to a high number of people who are suffering from substance abuse or alcohol addiction. According to American Addiction Centers almost 74% of adults suffering from a substance use disorder in 2017 struggled with an alcohol use disorder. About 38% of adults in 2017 battled an illicit drug use disorder and 1 out of every 8 adults struggled with both alcohol and drug use disorders simultaneously. The high contribution due to the adaptation of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, large scale drug trafficking, that is being responsible for the growth of the market.

At-Home Drug of Abuse (DOA) Testing Market - Growth Rate by Region

Competitive Landscape

The At-Home Drug of Abuse (DOA) Testing Market is moderately competitive with several major players. Some of the major players are Abbott, Dragerwerk AG & Co. KGaA, UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Assure Tech.(Hangzhou) Co., LTD, Psychemedics Corporation.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Use and Production of Illicit Drugs

      2. 4.2.2 Increasing Initiatives by Governemnt Organizations to Reduce Drug Abuse

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness and Consideration of Drug Testing

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Test Cups

      2. 5.1.2 Test Strips

      3. 5.1.3 Others

    2. 5.2 By Sample Type

      1. 5.2.1 Saliva

      2. 5.2.2 Urine

      3. 5.2.3 Blood

      4. 5.2.4 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Dragerwerk AG & Co. KGaA

      3. 6.1.3 UCP Biosciences Inc.

      4. 6.1.4 Orient New Life Medical Co. Ltd.

      5. 6.1.5 Assure Tech.(Hangzhou) Co., LTD

      6. 6.1.6 Psychemedics Corporation

      7. 6.1.7 CONFIRM BIOSCIENCES

      8. 6.1.8 Phamatech Inc.

      9. 6.1.9 Home Health (UK) Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The At-Home Drug of Abuse (DOA) Testing Market market is studied from 2017 - 2025.

The At-Home Drug of Abuse (DOA) Testing Market is growing at a CAGR of 8.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2019.

Abbott, Dragerwerk AG & Co. KGaA, UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Assure Tech.(Hangzhou) Co., LTD are the major companies operating in At-Home Drug of Abuse (DOA) Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!